beta

AEZS

Æterna Zentaris, Inc.

Aezs

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC.

Market Cap: 14.2 Million

Primary Exchange: NASDAQ

Website: http://www.aezsinc.com

Shares Outstanding: 16.6 Million

Float: 16.6 Million

Dividend: (%)

Beta: 1.46839090082069

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Animal testing

Longest drawdown: 1739 trading days

From: 2013-01-29 To: 2019-12-06

Lowest Point:

Microcaps mostly among midday movers

via: SeekingAlpha at 2019-06-13 08:41:38:000

Gainers: Coda Octopus Group (NASDAQ: CODA ) +40% . Mmtec (NASDAQ: MTC ) +30% . Red Robin Gourmet Burgers (NASDAQ: RRGB ) +29% . DryShips (NASDAQ: DRYS ) +24% . Cemtrex (NASDAQ: CETX ) +21% . Ruhnn Holding Limited (NASDAQ: RUHN ) +21% . RH (NYSE: RH ) +20% . Aeterna Zentaris (N… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2015-11-20 100.0 1.0 100.0
Data provided by IEX Cloud